Published in Sarcoma on December 31, 2009
Inadequate Initial Resection. Dtsch Arztebl Int (2011) 0.91
Management of extremity soft tissue sarcomas. Indian J Orthop (2011) 0.81
Multimodality management of extremity soft tissue sarcomas-an Indian perspective. Indian J Surg Oncol (2012) 0.75
Adherence to Guidelines for Adult (Non-GIST) Soft Tissue Sarcoma in the Netherlands: A Plea for Dedicated Sarcoma Centers. Ann Surg Oncol (2017) 0.75
Cancer statistics, 2004. CA Cancer J Clin (2004) 15.72
Soft tissue sarcomas. CA Cancer J Clin (2004) 2.65
Surgical margins, local recurrence and metastasis in soft tissue sarcomas: 559 surgically-treated patients from the Scandinavian Sarcoma Group Register. Eur J Cancer (2000) 2.34
Residual disease following unplanned excision of soft-tissue sarcoma of an extremity. J Bone Joint Surg Am (1996) 2.26
Soft tissue tumours of the extremities. BMJ (2005) 2.04
Surgical resection of primary soft-tissue sarcoma. Incidence of residual tumour in 95 patients needing re-excision after local resection. J Bone Joint Surg Br (1996) 1.80
Effect of reresection in extremity soft tissue sarcoma. Ann Surg (2000) 1.80
Re-excision of soft tissue sarcoma after inadequate initial operation. Br J Surg (1995) 1.70
Soft-tissue sarcoma. J Am Acad Orthop Surg (2009) 1.42
The effect of an unplanned excision of a soft-tissue sarcoma on prognosis. J Bone Joint Surg Br (2008) 1.32
Should Soft Tissue Sarcomas be Treated at a Specialist Centre? Sarcoma (2004) 1.09
Surgical options and outcomes in bone sarcoma. Expert Rev Anticancer Ther (2006) 1.05
The management of soft tissue sarcoma. J Plast Reconstr Aesthet Surg (2008) 1.01
Unexpected resection of soft-tissue sarcoma. More mutilating surgery, higher local recurrence rates, and obscure prognosis as consequences of improper surgery. Arch Orthop Trauma Surg (2000) 0.97
Amputation for soft-tissue sarcoma. Lancet Oncol (2003) 0.95
Perioperative high-dose-rate brachytherapy in soft tissue sarcomas of the extremity and superficial trunk in adults: initial results of a pilot study. Brachytherapy (2005) 0.90
Amputation for recurrent soft tissue sarcoma of the extremity: indications and outcome. Ann Surg Oncol (2001) 0.86
Isolated limb perfusions with tumor necrosis factor and melphalan for locally recurrent soft tissue sarcoma in previously irradiated limbs. Ann Surg Oncol (2005) 0.86
Is radiotherapy important for low-grade soft tissue sarcoma of the extremity? Clin Orthop Relat Res (2001) 0.84
Use of brachytherapy in children with cancer: the search for an uncomplicated cure. Lancet Oncol (2006) 0.80
Factors Influencing Prognosis After Initial Inadequate Excision (IIE) for Soft Tissue Sarcoma. Sarcoma (2003) 0.80
Somatic mosaic IDH1 and IDH2 mutations are associated with enchondroma and spindle cell hemangioma in Ollier disease and Maffucci syndrome. Nat Genet (2011) 2.74
[Usefulness of PET scans in diagnosing recurrent prostate cancer. Prostate with PSA level < 5 ng/ml]. Actas Urol Esp (2009) 1.94
Intensity-modulated radiation therapy (IMRT) vs. 3D conformal radiotherapy (3DCRT) in locally advanced rectal cancer (LARC): dosimetric comparison and clinical implications. Radiat Oncol (2010) 1.32
Dedifferentiated chondrosarcoma: prognostic factors and outcome from a European group. Eur J Cancer (2007) 1.29
Prognostic factors and outcomes for osteosarcoma: an international collaboration. Eur J Cancer (2009) 1.19
Periosteal osteosarcoma--a European review of outcome. Eur J Cancer (2005) 1.07
Front-line paclitaxel/cisplatin-based chemotherapy in brain metastases from non-small-cell lung cancer. Oncology (2003) 1.01
Metal levels in corrosion of spinal implants. Eur Spine J (2007) 0.99
Analysis of polymorphisms of the vitamin D receptor, estrogen receptor, and collagen Ialpha1 genes and their relationship with height in children with bone cancer. J Pediatr Hematol Oncol (2003) 0.99
Surgical resection after preoperative chemoradiotherapy benefits selected patients with unresectable pancreatic cancer. Am J Clin Oncol (2003) 0.97
Proteomic analysis of chemonaive pediatric osteosarcomas and corresponding normal bone reveals multiple altered molecular targets. J Proteome Res (2009) 0.96
Long-term results after resection for bone sarcoma pulmonary metastases. Eur J Cardiothorac Surg (2009) 0.95
Patterns of response after preoperative treatment in gastric cancer. Int J Radiat Oncol Biol Phys (2010) 0.91
FHL2 silencing reduces Wnt signaling and osteosarcoma tumorigenesis in vitro and in vivo. PLoS One (2013) 0.91
Corrosion and late infection causing delayed paraparesis after spinal instrumentation. J Pediatr Orthop B (2006) 0.90
Four-week neoadjuvant intensity-modulated radiation therapy with concurrent capecitabine and oxaliplatin in locally advanced rectal cancer patients: a validation phase II trial. Int J Radiat Oncol Biol Phys (2011) 0.89
Pilot clinical trial of type 1 dendritic cells loaded with autologous tumor lysates combined with GM-CSF, pegylated IFN, and cyclophosphamide for metastatic cancer patients. J Immunol (2011) 0.89
Treatment of upper gum carcinoma with high-dose-rate customized-mold brachytherapy. Brachytherapy (2008) 0.87
Cortactin (CTTN) overexpression in osteosarcoma correlates with advanced stage and reduced survival. Cancer Biomark (2012) 0.87
Spinal extradural arachnoid cysts in lymphedema-distichiasis syndrome. Genet Med (2010) 0.86
Use of customized-mold brachytherapy in the management of malignancies arising in the maxillary antrum after maxillectomy: a dosimetric analysis. Brachytherapy (2010) 0.86
Serum Amyloid A concentration is increased in obese children and adolescents. J Pediatr (2008) 0.85
Dosimetric analysis of the patterns of local failure observed in patients with locally advanced non-small cell lung cancer treated with neoadjuvant chemotherapy and concurrent conformal (3D-CRT) chemoradiation. Radiother Oncol (2008) 0.84
Salvage brachytherapy in prostate local recurrence after radiation therapy: predicting factors for control and toxicity. Radiat Oncol (2014) 0.83
Irinotecan, oxaliplatin, and 5-fluorouracil/leucovorin combination chemotherapy in advanced colorectal carcinoma: a phase II study. Clin Colorectal Cancer (2002) 0.83
Randomized crossover pharmacokinetic evaluation of subcutaneous versus intravenous granisetron in cancer patients treated with platinum-based chemotherapy. Oncologist (2007) 0.83
Synergistic effects of CTLA-4 blockade with tremelimumab and elimination of regulatory T lymphocytes in vitro and in vivo. Int J Cancer (2010) 0.83
KRAS mutational status analysis of peripheral blood isolated circulating tumor cells in metastatic colorectal patients. Oncol Lett (2013) 0.83
Thymidylate synthase polymorphisms in genomic DNA as clinical outcome predictors in a European population of advanced non-small cell lung cancer patients receiving pemetrexed. J Transl Med (2014) 0.82
Clinical practice guidelines on antiemetics in oncology. Expert Rev Anticancer Ther (2005) 0.82
Clinical management of small-cell carcinoma of the urinary tract: a 10-year single-center's experience. Clin Genitourin Cancer (2012) 0.81
The oncolytic adenovirus Δ24-RGD in combination with cisplatin exerts a potent anti-osteosarcoma activity. J Bone Miner Res (2014) 0.81
Docetaxel plus vinorelbine as salvage chemotherapy in advanced breast cancer: a phase II study. Breast Cancer Res Treat (2002) 0.80
Phase I-II trial of concurrent capecitabine and oxaliplatin with preoperative intensity-modulated radiotherapy in patients with locally advanced rectal cancer. Int J Radiat Oncol Biol Phys (2007) 0.80
Limb salvage in Ewing's sarcoma of the distal lower extremity. Foot Ankle Int (2008) 0.78
Activity of gefitinib in central nervous system metastases in patients with non-small-cell lung cancer: two case reports and a review of the literature. Clin Lung Cancer (2005) 0.78
Long-term results of 1-week intravaginal high-dose-rate brachytherapy alone for endometrial cancer. Brachytherapy (2012) 0.78
VEGF, BMP-7, Matrigel(TM), hyaluronic acid, in vitro cultured chondrocytes and trephination for healing of the avascular portion of the meniscus. An experimental study in sheep. Curr Stem Cell Res Ther (2014) 0.77
Combined irinotecan, oxaliplatin and 5-fluorouracil in patients with advanced colorectal cancer. a feasibility pilot study. Oncology (2002) 0.77
Differential expression of prostaglandin D2 synthase (PTGDS) in patients with attention deficit-hyperactivity disorder and bipolar disorder. J Affect Disord (2012) 0.77
Transvaginal color Doppler sonography for predicting response to concurrent chemoradiotherapy for locally advanced cervical carcinoma. J Clin Ultrasound (2004) 0.77
Radiation therapy after high-dose chemotherapy with peripheral blood stem cell support for high-risk breast cancer. Am J Clin Oncol (2002) 0.76
Targeting the E3 ubiquitin casitas B-lineage lymphoma decreases osteosarcoma cell growth and survival and reduces tumorigenesis. J Bone Miner Res (2012) 0.76
Measurement and analysis of the chemotherapy-induced genetic instability in pediatric cancer patients. Mutagenesis (2002) 0.76
Analysis of BRCA1 and mtDNA haplotypes and mtDNA polymorphism in familial breast cancer. Mitochondrial DNA (2013) 0.76
Early breast cancer treated with conservative surgery, adjuvant chemotherapy, and delayed accelerated partial breast irradiation with high-dose-rate brachytherapy. Brachytherapy (2008) 0.76
Phase II trial of radiation dose escalation with conformal external beam radiotherapy and high-dose-rate brachytherapy combined with long-term androgen suppression in unfavorable prostate cancer: feasibility report. Int J Radiat Oncol Biol Phys (2009) 0.76
Antitumoral-Lipid-Based Nanoparticles: a Platform for Future Application in Osteosarcoma therapy. Curr Pharm Des (2015) 0.76
A novel BRCA1 mutation in a patient with breast and ovarian cancer: A case report. Oncol Lett (2013) 0.75
Correction: Characterization of the Antiglioma Effect of the Oncolytic Adenovirus VCN-01. PLoS One (2016) 0.75
Pediatric meningosarcoma: clinical evolution and genetic instability. Pediatr Neurol (2005) 0.75
Sequential administration of dose-dense epirubicin/cyclophosphamide followed by docetaxel/capecitabine for patients with HER2-negative and locally advanced or node-positive breast cancer. Cancer Chemother Pharmacol (2009) 0.75
Central retinal vascular occlusion by orbital pseudotumor. Retina (2004) 0.75
A new mutation in the hMSH2 gene in a Spanish Lynch syndrome family. Clin Transl Oncol (2010) 0.75
Relationship between Day 0 dosimetric parameters and biochemical relapse-free survival in patients treated with transperineal permanent prostate interstitial brachytherapy with (125)I seeds. Brachytherapy (2009) 0.75
Paclitaxel, cisplatin, and vinorelbine combination chemotherapy in metastatic non-small-cell lung cancer. Am J Clin Oncol (2004) 0.75
Concomitant cisplatin, paclitaxel, and hyperfractionated radiotherapy in locally advanced head and neck cancer: comparison of two different schedules. Am J Clin Oncol (2010) 0.75
Comparison of limited-volume perioperative high-dose-rate brachytherapy and wide-field external irradiation in resected head and neck cancer. Head Neck (2012) 0.75
Exome array analysis identifies GPR35 as a novel susceptibility gene for anthracycline-induced cardiotoxicity in childhood cancer. Pharmacogenet Genomics (2017) 0.75
Long-Term Results of a Phase II Trial of Concomitant Cisplatin-Paclitaxel Chemoradiation in Locally Advanced Cervical Cancer. Int J Gynecol Cancer (2016) 0.75
Patterns of response after preoperative intensity-modulated radiation therapy and capecitabine/oxaliplatin in rectal cancer: is there still a place for ecoendoscopic ultrasound? Int J Radiat Oncol Biol Phys (2010) 0.75
[Unexpected diagnosis in the case of a 16-year-old boy with back pain]. Med Clin (Barc) (2012) 0.75